Phoenix
  • News
  • About
  • Investments
  • Team
  • Partners
  • Contact
Select Page
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

Apr 16, 2018

Collaboration will provide clients competitive advantages, improve speed to market. KBI makes equity investment in ReForm Biologics along with existing investors. CAMBRIDGE, Mass. and Durham, NC – April 4, 2018 – ReForm Biologics and KBI Biopharma, Inc., (KBI) today...

Recent Posts

  • ‘Protein printing’ AbSci secures $125M crossover as it expands synthetic biology ambitions
  • AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform
  • L7 Informatics Raises $13M in Series B Financing
  • ReForm taps ex-Genzyme exec to lead subcutaneous delivery strategy
  • 8 Female Venture Capital Investors To Watch In 2021

Categories

  • Article
  • Interview
  • News
  • Press Release
  • Show All